Summary
- Current Price
- As of today, ENTA price is $13.11, down -2.24% in the most recent trading session on
- Current Price All-Time High
- ENTA price is currently -89.74% below its historical high of $127.77 set on
- Market Cap
- ENTA current market cap is $380M, up +161.11% over the past 365 days
- PE Ratio
- ENTA PE ratio is unknown
- Revenue
- ENTA current annual revenue is $65.32M, down -3.42% year-over-year
- Next Earnings
- The next earnings release for ENTA is on
Profile
| Metric | Value |
|---|---|
| Full Name | Enanta Pharmaceuticals, Inc. |
| Ticker | NASDAQ: ENTA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | enanta.com |
| Employees | 131 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $13.11 | ||
| Price, 1D Change | -2.24% | |
| $380M | ||
| - | ||
| - | ||
| 0.89 | ||
| $65M | ||
| Revenue, 1Y Change | -3.42% | |
| -$3.84 | ||
| EPS, 1Y Change | +30.03% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$3.84 | ||
| EPS Estimate | N/A | -$2.13 |
| EPS Est. Change | N/A | +44.63% |
| $65.32M | ||
| Revenue Estimate | N/A | $66.41M |
| Revenue Est. Change | N/A | +1.67% |
| $13.11 | ||
| Price Target | - | $20.00 |
| Price Tgt. Change | - | +52.56% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$5.18 | -$5.49 | -5.97% | |
| -$3.75 | -$3.84 | -2.43% | |
| -$2.13 | N/A | +44.63% | |
| -$2.48 | N/A | +35.47% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $71.19M | $67.64M | -4.99% | |
| $66.15M | $65.32M | -1.25% | |
| $66.41M | N/A | +1.67% | |
| $64.03M | N/A | -1.99% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +91.95% | ||
| -70.91% | ||
| +161.11% | ||
| -59.59% | ||
| -3.42% | ||
| -24.18% | ||
| +30.03% | ||
| +35.05% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $13.11 | ||
| $10.74 | ||
| SMA 200 vs Price | -18.05% | |
| $13.72 | ||
| SMA 50 vs Price | +4.64% | |
| 0.89 | ||
| $0.81 | ||
| 44.46 | ||
| 71.13% | ||
| 113.05% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $65.32M | ||
| -$3.84 | ||
| $0.00 | ||
| 0.00% | ||
| -$85.35M | ||
| -130.65% | ||
| -$81.89M | ||
| -125.36% | ||
| -$80.76M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 3.11 | ||
| 4.21 | ||
| 4.21 | ||
| - | ||
| 3 | ||
| -1.04 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 5.68 | ||
| 3.01 | ||
| -5.69 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $64.72M | ||
| $188.86M | ||
| $292.72M | ||
| $204.34M | ||
| $228.00M | ||
| $48.56M | ||
| $201.06M | ||
| $33.86M | ||
| $1.95M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $147.21M | ||
| $85.35M | ||
| $4.59M | ||
| $0.00 | ||
| $4.59M | ||
| $0.00 | ||
| -$1.66M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$19.27M | ||
| $40.35M | ||
| -$26.62M | ||
| $12.90M | ||
| -$32.17M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| JP Morgan | ||
| Jefferies | → | |
| WestPark Capital | → | |
| Evercore ISI Group | → | |
| WestPark Capital | ||
| JMP Securities | → | |
| JMP Securities | → | |
| JMP Securities | → |
Analyst sentiment
Institutional ownership
Screeners with ENTA
FAQ
What is the ticker symbol for Enanta Pharmaceuticals, Inc.?
The ticker symbol for Enanta Pharmaceuticals, Inc. is NASDAQ:ENTA
Does Enanta Pharmaceuticals, Inc. pay dividends?
No, Enanta Pharmaceuticals, Inc. does not pay dividends
What sector is Enanta Pharmaceuticals, Inc. in?
Enanta Pharmaceuticals, Inc. is in the Healthcare sector
What industry is Enanta Pharmaceuticals, Inc. in?
Enanta Pharmaceuticals, Inc. is in the Biotechnology industry
What country is Enanta Pharmaceuticals, Inc. based in?
Enanta Pharmaceuticals, Inc. is headquartered in United States
When did Enanta Pharmaceuticals, Inc. go public?
Enanta Pharmaceuticals, Inc. initial public offering (IPO) was on March 21, 2013
Is Enanta Pharmaceuticals, Inc. in the S&P 500?
No, Enanta Pharmaceuticals, Inc. is not included in the S&P 500 index
Is Enanta Pharmaceuticals, Inc. in the NASDAQ 100?
No, Enanta Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
Is Enanta Pharmaceuticals, Inc. in the Dow Jones?
No, Enanta Pharmaceuticals, Inc. is not included in the Dow Jones index
When was Enanta Pharmaceuticals, Inc. last earnings report?
Enanta Pharmaceuticals, Inc.'s most recent earnings report was on February 9, 2026
When does Enanta Pharmaceuticals, Inc. report earnings?
The next expected earnings date for Enanta Pharmaceuticals, Inc. is May 11, 2026
Data Sources & References
- ENTA Official Website www.enanta.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1177648/000119312526046502/0001193125-26-046502-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1177648/000119312525288121/0001193125-25-288121-index.htm
- ENTA Profile on Yahoo Finance finance.yahoo.com/quote/ENTA
- ENTA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/enta